Renal, Bladder, Prostate and Testicular Cancer

TESTICULAR AND RENAL CANCER. Testicular germ cell tumors, an update. Surgery for testicular cancer - indications, technique and results. Chemotherapy for testicular cancer. RENAL CARCINOMA. Prognostic factors and treatment decisions. Laparoscopic radical nephrectomy and nephroureterectomy for treatment of renal cell and transitional cell carcinoma. Modern management of advanced renal cell carcinoma. New applications of cytokines: inhalation of interleukin-2 to control pulmonary metastases. Management of advanced renal cell carcinoma. PROSTATE CANCER: EARLY DIAGNOSIS AND NATURAL HISTORY. Molecular markers (PSA, hK2, RT-PCR of PSA and hk2 mRNA). Early diagnosis. Characteristics of prostate cancer in different prostate-specific antigen ranges. How accurately does biopsy information determine outcome? Laparoscopic radical prostatectomy. MANAGEMENT OF LOCALIZED PROSTATE CANCER AND PREVENTATIVE APPROACHES. Watchful waiting or early endocrine treatment in 'low risk' prostate cancer. Biochemical outcome after radical prostatectomy, external beam radiation therapy or interstitial radiation therapy for clinically localized prostate cancer. Screening for prostate cancer - is mortality reduction already proven? Chemo-endocrine prevention. PROSTATE CANCER: ENDOCRINE TREATMENT. The molecular mechanisms of hormone resistance in prostate cancer. Early versus delayed endocrine therapy. Antiandrogen monotherapy - better quality of life? Metastatic prostate cancer - a randomized study of cyproterone acetate versus flutamide. Intermittent androgen suppression. PROSTATE CANCER: ADVANCED. Adjuvant and neoadjuvant treatment of prostate cancer. Gene therapy in urology. Non-endocrine systemic approaches for prostate cancer. BLADDER CANCER. Novel detection strategies for transitional cell carcinoma. Transurethral resection of bladder cancer controlled by 5-aminolevulinic acid-induced fluorescence endoscopy. Ta-T1 G1-G2 transitional cell carcinoma. BCG in transitional cell carcinoma - schedules of application, results and limitations. The approach to high-grade transitional cell carcinoma in Ta, CIS and T1 stages. Brachytherapy for transitional cell carcinoma of the bladder (category / T1 G3): an alternative to cystectomy? Current status of systemic treatment in locally advanced and metastatic bladder cancer. Index.